ABBV RSI Chart
Last 7 days
2.0%
Last 30 days
9.3%
Last 90 days
28.3%
Trailing 12 Months
16.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 56.7B | 56.0B | 55.1B | 54.3B |
2022 | 56.7B | 57.3B | 57.8B | 58.1B |
2021 | 50.2B | 53.7B | 55.2B | 56.2B |
2020 | 34.1B | 36.2B | 40.6B | 45.8B |
2019 | 32.6B | 32.6B | 32.9B | 33.3B |
2018 | 29.6B | 30.9B | 32.2B | 32.8B |
2017 | 26.2B | 26.7B | 27.3B | 28.2B |
2016 | 23.8B | 24.8B | 25.2B | 25.6B |
2015 | 20.4B | 21.0B | 21.9B | 22.9B |
2014 | 19.0B | 19.3B | 19.6B | 20.0B |
2013 | 18.5B | 18.7B | 18.9B | 18.8B |
2012 | 17.7B | 17.9B | 18.1B | 18.4B |
2011 | 0 | 0 | 0 | 17.4B |
2010 | 0 | 0 | 0 | 15.6B |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 01, 2024 | richmond timothy j. | acquired | 2,804,150 | 61.36 | 45,700 | evp, chief hr officer |
Mar 01, 2024 | richmond timothy j. | sold | -13,415,500 | 177 | -75,680 | evp, chief hr officer |
Feb 29, 2024 | siatis perry c | sold | -1,754,550 | 177 | -9,891 | evp, gc and secretary |
Feb 29, 2024 | buckbee kevin k | sold | -908,688 | 176 | -5,144 | svp, controller |
Feb 29, 2024 | michael robert a. | acquired | 1,257,010 | 58.303 | 21,560 | pres & chief operating officer |
Feb 29, 2024 | michael robert a. | sold | -12,154,000 | 176 | -68,879 | pres & chief operating officer |
Feb 28, 2024 | saleki-gerhardt azita | sold (taxes) | -4,289,670 | 178 | -23,966 | evp, chief operations officer |
Feb 28, 2024 | gonzalez richard a | sold (taxes) | -19,733,500 | 178 | -110,249 | chairman of the board and ceo |
Feb 28, 2024 | reents scott t | sold (taxes) | -2,082,370 | 178 | -11,634 | evp, chief financial officer |
Feb 28, 2024 | thakkar roopal | sold (taxes) | -879,557 | 178 | -4,914 | svp, cmo, global therapeutics |
Which funds bought or sold ABBV recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 15, 2024 | Skyline Advisors, Inc. | new | - | 229,895 | 229,895 | 0.11% |
Mar 15, 2024 | CAPE ANN SAVINGS BANK | reduced | -0.32 | 185,066 | 2,047,270 | 1.35% |
Mar 15, 2024 | B. Riley Wealth Advisors, Inc. | reduced | -10.45 | -1,495,020 | 20,180,100 | 0.54% |
Mar 14, 2024 | ABLES, IANNONE, MOORE & ASSOCIATES, INC. | new | - | 37,038 | 37,038 | 0.03% |
Mar 14, 2024 | Leo Wealth, LLC | new | - | 2,915,070 | 2,915,070 | 0.30% |
Mar 14, 2024 | WALDEN WEALTH PARTNERS LLC | new | - | 221,532 | 221,532 | 0.14% |
Mar 13, 2024 | MONECO Advisors, LLC | reduced | -10.00 | -95,418 | 1,388,320 | 0.26% |
Mar 13, 2024 | Sivia Capital Partners, LLC | new | - | 571,668 | 571,668 | 0.44% |
Mar 12, 2024 | Spartan Planning & Wealth Management | added | 295 | 252,097 | 333,186 | 0.36% |
Mar 12, 2024 | Cove Private Wealth, LLC | new | - | 426,168 | 426,168 | 0.40% |
Unveiling AbbVie Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to AbbVie Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 377.6B | 93.0B | 10.74 | 4.43 | ||||
MRK | 307.6B | 60.1B | 842.64 | 5.12 | ||||
PFE | 156.5B | 46.5B | -112.73 | 3.36 | ||||
AMGN | 145.1B | 28.2B | 21.61 | 5.15 | ||||
GILD | 91.3B | 27.1B | 16.11 | 3.37 | ||||
TEVA | 14.9B | 15.8B | -25.9 | 0.94 | ||||
MID-CAP | ||||||||
ALKS | 4.6B | 1.7B | 12.93 | 2.77 | ||||
PRGO | 4.1B | 4.7B | -320.22 | 0.87 | ||||
BHC | 3.4B | 8.8B | -5.79 | 0.39 | ||||
AMPH | 2.1B | 644.4M | 14.98 | 3.2 | ||||
SMALL-CAP | ||||||||
TLRY | 1.4B | 700.5M | -1 | 2.04 | ||||
TXMD | 24.4M | 70.0M | 0.36 | 0.34 | ||||
ACRX | 19.5M | - | -1.06 | 0.22 | ||||
ACOR | 16.8M | 111.1M | -1.05 | 0.15 | ||||
AGRX | 1.4M | 20.0M | -0.1 | 0.07 |
AbbVie Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 2.7% | 14,301 | 13,927 | 13,865 | 12,225 | 15,121 | 14,812 | 14,583 | 13,538 | 14,886 | 14,342 | 13,959 | 13,010 | 13,858 | 12,902 | 10,425 | 8,619 | 8,704 | 8,479 | 8,255 | 7,828 | 8,305 |
Costs and Expenses | -4.6% | 11,106 | 11,646 | 9,352 | 9,457 | 9,619 | 10,209 | 11,288 | 8,821 | 9,812 | 10,036 | 9,518 | 8,907 | 10,105 | 9,647 | 9,673 | 5,016 | 4,748 | 5,862 | 4,855 | 4,818 | 10,746 |
S&GA Expenses | -5.3% | 3,193 | 3,372 | 3,268 | 3,039 | 3,417 | 3,304 | 5,412 | 3,127 | 3,260 | 3,083 | 3,164 | 2,842 | 3,231 | 2,846 | 3,527 | 1,695 | 1,951 | 1,657 | 1,654 | 1,680 | 1,929 |
EBITDA Margin | -14.3% | 0.18* | 0.21* | 0.25* | 0.22* | 0.29* | 0.32* | 0.31* | 0.31* | 0.29* | 0.19* | 0.18* | 0.15* | - | - | - | - | - | - | - | - | - |
Income Taxes | 125.6% | 388 | 172 | 583 | 234 | 493 | 448 | 255 | 436 | 226 | 508 | 394 | 312 | -1,545 | 187 | 46.00 | 88.00 | 273 | 117 | 66.00 | 88.00 | -547 |
Earnings Before Taxes | -37.9% | 1,212 | 1,953 | 2,610 | 475 | 2,965 | 4,400 | 1,183 | 4,929 | 4,271 | 3,688 | 1,163 | 3,867 | -1,507 | 2,500 | -693 | 3,098 | 3,074 | 2,001 | 807 | 2,544 | -2,373 |
EBT Margin | -20.7% | 0.12* | 0.15* | 0.19* | 0.16* | 0.23* | 0.26* | 0.25* | 0.25* | 0.23* | 0.13* | 0.11* | 0.08* | - | - | - | - | - | - | - | - | - |
Net Income | -53.8% | 822 | 1,778 | 2,024 | 239 | 2,473 | 3,949 | 924 | 4,490 | 4,044 | 3,179 | 766 | 3,553 | 36.00 | 2,308 | -738 | 3,010 | 2,801 | 1,884 | 741 | 2,456 | -1,826 |
Net Income Margin | -24.2% | 0.09* | 0.12* | 0.16* | 0.13* | 0.20* | 0.23* | 0.22* | 0.22* | 0.21* | 0.14* | 0.12* | 0.10* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -38.2% | 4,548 | 7,355 | 6,141 | 4,018 | 7,215 | 7,425 | 4,862 | 4,746 | 4,888 | 7,718 | 4,695 | 4,689 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -1.1% | 134,711 | 136,221 | 135,367 | 134,544 | 138,805 | 141,325 | 143,186 | 143,211 | 146,529 | 148,858 | 147,972 | 150,501 | 150,565 | 149,621 | 149,530 | 91,199 | 89,115 | 59,441 | 57,142 | 56,769 | 59,352 |
Current Assets | -0.7% | 33,002 | 33,224 | 28,852 | 26,488 | 28,463 | 30,364 | 29,100 | 26,509 | 27,928 | 28,957 | 25,999 | 26,569 | 24,173 | 23,009 | 21,256 | 51,758 | 49,519 | 20,166 | 15,100 | 14,413 | 16,945 |
Cash Equivalents | -3.6% | 12,814 | 13,287 | 8,759 | 6,711 | 9,201 | 11,832 | 8,521 | 6,098 | 9,746 | 12,182 | 8,546 | 9,755 | 8,449 | 7,890 | 6,017 | 41,142 | 39,924 | 10,648 | 5,172 | 4,897 | 7,289 |
Inventory | 3.0% | 4,099 | 3,981 | 4,055 | 3,833 | 3,579 | 3,172 | 3,396 | 3,483 | 3,128 | 3,094 | 3,386 | 3,272 | 3,310 | 3,474 | 4,059 | 1,844 | 1,813 | 1,929 | 1,895 | 1,702 | 1,605 |
Net PPE | 1.1% | 4,989 | 4,934 | 4,943 | 4,931 | 4,935 | 4,893 | 4,958 | 5,075 | 5,110 | 5,130 | 5,161 | 5,193 | 5,248 | 4,986 | 4,908 | 2,961 | 2,962 | 2,894 | 2,879 | 2,860 | 2,883 |
Goodwill | 0.6% | 32,293 | 32,091 | 32,224 | 32,220 | 32,156 | 31,726 | 32,028 | 32,298 | 32,379 | 32,296 | 32,398 | 32,349 | 33,124 | 42,801 | 42,669 | 15,561 | 15,604 | 15,537 | 15,642 | 15,606 | 15,663 |
Current Liabilities | 8.8% | 37,841 | 34,773 | 32,239 | 27,590 | 29,538 | 32,712 | 34,473 | 32,521 | 35,194 | 28,533 | 28,684 | 31,951 | 28,661 | 24,181 | 24,646 | 16,471 | 15,585 | 17,493 | 16,941 | 13,904 | 17,239 |
Short Term Borrowings | -100.0% | - | 2.00 | - | 1.00 | 1.00 | 10.00 | 17.00 | 12.00 | 14.00 | 16.00 | 17.00 | 9.00 | 34.00 | 54.00 | 64.00 | 6.00 | - | - | 306 | 499 | 3,699 |
Long Term Debt | -6.2% | 52,194 | 55,631 | 55,812 | 59,292 | 59,135 | 60,399 | 61,002 | 63,522 | 64,189 | 74,049 | 74,237 | 74,183 | 77,554 | 82,282 | 82,061 | 63,284 | 62,975 | 33,126 | 31,619 | 35,066 | 35,002 |
Shareholder's Equity | -14.3% | 10,360 | 12,094 | 12,898 | 13,303 | 17,254 | 16,027 | 14,688 | 16,314 | 15,436 | 13,577 | 12,594 | 13,733 | 13,097 | 15,289 | 14,732 | - | - | - | - | - | - |
Retained Earnings | -207.2% | -1,000 | 933 | 1,789 | 2,393 | 4,784 | 4,953 | 3,516 | 5,103 | 3,127 | 1,600 | 740 | 2,292 | 1,055 | 3,335 | 3,130 | 5,973 | 4,717 | 3,673 | 3,384 | 4,234 | 3,368 |
Additional Paid-In Capital | 0.8% | 20,180 | 20,021 | 19,839 | 19,619 | 19,245 | 19,056 | 18,906 | 18,731 | 18,305 | 18,108 | 17,936 | 17,712 | 17,384 | 17,148 | 16,953 | 15,401 | 15,193 | 15,112 | 15,028 | 14,940 | 14,756 |
Shares Outstanding | 0.1% | 1,768 | 1,767 | 1,768 | 1,770 | 1,771 | 1,771 | 1,770 | 1,771 | 1,770 | 1,769 | 1,769 | 1,769 | - | - | - | - | - | - | - | - | - |
Minority Interest | 5.7% | 37.00 | 35.00 | 32.00 | 29.00 | 33.00 | 33.00 | 35.00 | 31.00 | 28.00 | 27.00 | 25.00 | 23.00 | 21.00 | 19.00 | 24.00 | - | - | - | - | - | - |
Float | - | - | - | 235,630 | - | - | - | 268,253 | - | - | - | 197,246 | - | - | - | 171,597 | - | - | - | 106,362 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -37.2% | 4,753 | 7,574 | 6,319 | 4,193 | 7,428 | 7,602 | 5,005 | 4,908 | 5,075 | 7,935 | 4,890 | 4,877 | 4,854 | 5,830 | 3,089 | 3,815 | 3,275 | 4,555 | 2,477 | 3,017 | 3,392 |
Share Based Compensation | -3.8% | 125 | 130 | 179 | 313 | 132 | 126 | 107 | 306 | 129 | 135 | 159 | 269 | 136 | 162 | 236 | 219 | 79.00 | 75.00 | 87.00 | 189 | 70.00 |
Cashflow From Investing | -116.8% | -800 | -369 | -341 | -499 | -448 | 1,286 | 130 | -1,591 | -1,145 | -615 | -242 | -342 | -627 | -1,149 | -35,652 | -129 | -615 | 1,378 | -140 | -27.00 | -283 |
Cashflow From Financing | -67.2% | -4,449 | -2,661 | -3,920 | -6,192 | -9,634 | -5,518 | -2,679 | -6,972 | -6,338 | -3,643 | -5,884 | -3,174 | -3,695 | -2,814 | -2,570 | -2,422 | 26,602 | -441 | -2,070 | -5,383 | -3,825 |
Dividend Payments | 0.0% | 2,626 | 2,627 | 2,625 | 2,661 | 2,506 | 2,504 | 2,507 | 2,526 | 2,314 | 2,315 | 2,310 | 2,322 | 2,101 | 2,100 | 1,752 | 1,763 | 1,595 | 1,591 | 1,592 | 1,588 | 1,451 |
Buy Backs | -25.0% | 3.00 | 4.00 | 10.00 | 1,955 | 4.00 | 4.00 | 9.00 | 1,470 | 131 | 6.00 | 10.00 | 787 | 296 | 20.00 | 19.00 | 643 | 2.00 | 4.00 | 3.00 | 620 | 2,058 |
Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | |||
Net revenues | $ 54,318 | $ 58,054 | $ 56,197 |
Cost of products sold | 20,415 | 17,414 | 17,446 |
Selling, general and administrative | 12,872 | 15,260 | 12,349 |
Research and development | 7,675 | 6,510 | 6,922 |
Acquired IPR&D and milestones | 778 | 697 | 1,124 |
Other operating expense (income), net | (179) | 56 | 432 |
Total operating costs and expenses | 41,561 | 39,937 | 38,273 |
Operating earnings | 12,757 | 18,117 | 17,924 |
Interest expense, net | 1,684 | 2,044 | 2,384 |
Net foreign exchange loss | 146 | 148 | 51 |
Other expense, net | 4,677 | 2,448 | 2,500 |
Earnings before income tax expense | 6,250 | 13,477 | 12,989 |
Income tax expense | 1,377 | 1,632 | 1,440 |
Net earnings | 4,873 | 11,845 | 11,549 |
Net earnings attributable to noncontrolling interest | 10 | 9 | 7 |
Net earnings attributable to AbbVie Inc. | $ 4,863 | $ 11,836 | $ 11,542 |
Per share data | |||
Basic earnings per share (in dollars per share) | $ 2.73 | $ 6.65 | $ 6.48 |
Diluted earnings per share (in dollars per share) | $ 2.72 | $ 6.63 | $ 6.45 |
Weighted-average basic shares outstanding (in shares) | 1,768 | 1,771 | 1,770 |
Weighted-average diluted shares outstanding (in shares) | 1,773 | 1,778 | 1,777 |
Consolidated Balance Sheets - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and equivalents | $ 12,814 | $ 9,201 |
Short-term investments | 2 | 28 |
Accounts receivable, net | 11,155 | 11,254 |
Inventories | 4,099 | 3,579 |
Prepaid expenses and other | 4,932 | 4,401 |
Total current assets | 33,002 | 28,463 |
Investments | 304 | 241 |
Property and equipment, net | 4,989 | 4,935 |
Intangible assets, net | 55,610 | 67,439 |
Goodwill | 32,293 | 32,156 |
Other assets | 8,513 | 5,571 |
Total assets | 134,711 | 138,805 |
Current liabilities | ||
Short-term borrowings | 0 | 1 |
Current portion of long-term debt and finance lease obligations | 7,191 | 4,135 |
Accounts payable and accrued liabilities | 30,650 | 25,402 |
Total current liabilities | 37,841 | 29,538 |
Long-term debt and finance lease obligations | 52,194 | 59,135 |
Deferred income taxes | 1,952 | 2,190 |
Other long-term liabilities | 32,327 | 30,655 |
Commitments and contingencies | ||
Stockholders' equity | ||
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,823,046,087 shares issued as of December 31, 2023 and 1,813,770,294 as of December 31, 2022 | 18 | 18 |
Common stock held in treasury, at cost, 57,105,354 shares as of December 31, 2023 and 44,589,000 as of December 31, 2022 | (6,533) | (4,594) |
Additional paid-in capital | 20,180 | 19,245 |
Retained earnings (accumulated deficit) | (1,000) | 4,784 |
Accumulated other comprehensive loss | (2,305) | (2,199) |
Total stockholders' equity | 10,360 | 17,254 |
Noncontrolling interest | 37 | 33 |
Total equity | 10,397 | 17,287 |
Total liabilities and equity | $ 134,711 | $ 138,805 |
 | Mr. Richard A. Gonzalez |
---|---|
 | www.abbvie.com |
 | 50000 |